The global demand for Erythropoietin Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028. Regarding volume, the market was calculated XX Kilo Tons in 2021 and forecast to touch XX Kilo Tons by 2028 with a CAGR of XX% during 2022-2028.
Erythropoietin (EPO) is also identified as haemopoietin or haematopoietin. It is a glycoprotein hormone secreted by the kidneys and also the liver and brain in small amounts. It plays a significant role in the formation of red blood cells (RBCs), which are responsible for carrying oxygen from the lungs through the bloodstream to other parts of the body. Erythropoietin stimulating agents (ESAs) are generally administered to patients suffering from anemia resulting from chronic kidney disease (CKD), end-stage renal disease (ESRD), and human immunodeficiency virus (HIV), as their body cannot produce the required level of erythropoietin. Erythropoietin drugs are also used to treat chemotherapy-induced anemia.
Market Dynamics
The key factors driving the erythropoietin drug market are the increasing occurrence of anemia owing to chronic diseases such as cancer, HIV, and end-stage renal disease, increasing prevalence of ART-induced anemia, and growing demand for biologic and biosimilar drugs. Anaemia is a severe global public health condition that predominantly affects elders, young children, and pregnant women. According to the World Health Organization, globally, anaemia affects 1.62 billion people, corresponding to 24.8% of the population. Favorable reimbursement policies, fast erythropoietin drug approvals, substantial investment by the government for R&D activities to manufacture the drug, and increasing awareness about EPO are other factors that propel erythropoietin drug market growth. Furthermore, patent expiry is another crucial factor boosting the demand for these drugs. However, factors like high cost, lack of knowledge about proper usage, and the Covid-19 pandemic may hinder the growth of the erythropoietin drug market.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of erythropoietin. The growth and trends of Erythropoietin Industry provide a holistic approach to this study.
Market Segmentation
This section of the erythropoietin market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Epoetin-alfa
- Epoetin-beta
- Darbepoetin-alfa
- Others
By Application
- Hematology
- Kidney Disorder
- Cancer
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Erythropoietin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Erythropoietin Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the erythropoietin market include Amgen Inc., Johnson & Johnson, Hospira Inc., Roche, LG Life Sciences Ltd., Biocon, Intas Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., and Celltrion, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.